Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) today reported financial results for the third quarter ended September 30, 2024‎. Among other financial highlights, the Company generated $424,000 in positive Adjusted EBITDA¹ for the quarter on stable revenue. The Company's financial statements for the three and nine months ended September 30, 2024 and 2023 ‎and related Management's Discussion and Analysis (MD&A) are available under the Company's ‎profile on SEDAR+ (www.sedarplus.com).‎

Read more at globenewswire.com